You need to enable JavaScript to run this app.
FDA posts warning letters to manufacturers of breast binders
Regulatory News
Joanne S. Eglovitch
CDRH
Compliance
Medical Devices
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)
Warning letters